Risk for incident diabetes is greater in prediabetic men with HIV than without HIV
- PMID: 33859110
- PMCID: PMC8898036
- DOI: 10.1097/QAD.0000000000002922
Risk for incident diabetes is greater in prediabetic men with HIV than without HIV
Abstract
Background: Diabetes mellitus is a major comorbidity in people with HIV (PWH). Hyperglycemia below diabetic range defines prediabetes (prediabetes mellitus). We compared the progression from prediabetes mellitus to diabetes mellitus in PWH and people without HIV (PWOH).
Methods: Fasting glucose was measured semiannually in the MACS since 1999. Men with prediabetes mellitus (fasting glucose between 100 and 125 mg/dl, confirmed within a year by fasting glucose in the prediabetes mellitus range or HbA1c between 5.7 and 6.4%) were included. The first visit with prediabetes mellitus was the baseline visit. Incident diabetes mellitus was defined as fasting glucose at least 126 mg/dl, confirmed at a subsequent visit, or self-reported diabetes mellitus, or use of anti-diabetes mellitus medication. We used binomial transition models to compare the progression from prediabetes mellitus to diabetes mellitus by HIV serostatus, adjusted for age, number of previous prediabetes mellitus to diabetes mellitus transitions, ethnicity, BMI, family history of diabetes mellitus, and hepatitis C virus (HCV) infection.
Results: Between 1999 and 2019, 1584 men (793 PWH; 791 PWOH) with prediabetes mellitus were included. At baseline, PWH were younger (48 vs. 51 years, P < 0.01), had lower BMI (26 vs. 27), were more frequently nonwhite (47 vs. 30%), and HCV-infected as per last measure (8 vs. 4%) than PWOH (all P < 0.01). Over a median 12-year follow-up, 23% of participants developed diabetes mellitus. In adjusted analyses, the risk for incident diabetes mellitus was 40% (95% CI: 0--80%) higher among PWH than PWOH (P = 0.04).
Conclusion: Among men with prediabetes mellitus, PWH had an increased risk of incident diabetes mellitus adjusted for competing risk factors, warranting the evaluation of diabetes mellitus prevention strategies.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Conflicts of Interest
LS has served as a consultant to Gilead Sciences, Merck, ViiV. TTB has served as a consultant to ViiV Healthcare, Gilead Sciences, Merck, Theratechnologies, and Janssen. FJP has served on Advisory Boards and has done speaker programs for Gilead Sciences, Janssen, ViiV, Merck. JL has served as a consultant for Merck and Theratechnologies. JPV, JEL, AGA and BWB declared no conflict of interest.
Figures


Similar articles
-
Incident hyperglycaemia among older adults with or at-risk for HIV infection.Antivir Ther. 2011;16(2):181-8. doi: 10.3851/IMP1711. Antivir Ther. 2011. PMID: 21447867 Free PMC article.
-
Prevalence of Prediabetes Among Adolescents and Young Adults in the United States, 2005-2016.JAMA Pediatr. 2020 Feb 1;174(2):e194498. doi: 10.1001/jamapediatrics.2019.4498. Epub 2020 Feb 3. JAMA Pediatr. 2020. PMID: 31790544 Free PMC article.
-
High rates of incident diabetes and prediabetes are evident in men with treated HIV followed for 11 years.AIDS. 2018 Feb 20;32(4):451-459. doi: 10.1097/QAD.0000000000001709. AIDS. 2018. PMID: 29381559
-
Incidence and Risk Factors for Prediabetes and Diabetes Mellitus Among HIV-infected Adults on Antiretroviral Therapy: A Systematic Review and Meta-analysis.Epidemiology. 2018 May;29(3):431-441. doi: 10.1097/EDE.0000000000000815. Epidemiology. 2018. PMID: 29394189
-
Therapeutic Potential of Various Intermittent Fasting Regimens in Alleviating Type 2 Diabetes Mellitus and Prediabetes: A Narrative Review.Nutrients. 2024 Aug 14;16(16):2692. doi: 10.3390/nu16162692. Nutrients. 2024. PMID: 39203828 Free PMC article. Review.
Cited by
-
The prevalence of comorbidities and differences in noncommunicable diseases and nonrandom associations of comorbidities between HIV-infected and -uninfected individuals in Guangdong Province, China.BMC Public Health. 2025 Feb 24;25(1):761. doi: 10.1186/s12889-025-21780-x. BMC Public Health. 2025. PMID: 39994646 Free PMC article.
-
Diabetes in HIV: the Link to Weight Gain.Curr HIV/AIDS Rep. 2023 Feb;20(1):9-18. doi: 10.1007/s11904-022-00642-w. Epub 2022 Nov 23. Curr HIV/AIDS Rep. 2023. PMID: 36418528 Free PMC article. Review.
-
Infections and immunity: associations with obesity and related metabolic disorders.J Pathol Transl Med. 2023 Jan;57(1):28-42. doi: 10.4132/jptm.2022.11.14. Epub 2023 Jan 15. J Pathol Transl Med. 2023. PMID: 36647284 Free PMC article. Review.
-
Diabetes Risk Factors in People With HIV Receiving Pitavastatin Versus Placebo for Cardiovascular Disease Prevention : A Randomized Trial.Ann Intern Med. 2024 Nov;177(11):1449-1461. doi: 10.7326/ANNALS-24-00944. Epub 2024 Oct 8. Ann Intern Med. 2024. PMID: 39374532 Free PMC article. Clinical Trial.
-
Incident Proteinuria by HIV Serostatus Among Men With Pre--Diabetes Mellitus: The Multicenter AIDS Cohort Study.Clin Infect Dis. 2024 Aug 16;79(2):469-476. doi: 10.1093/cid/ciae065. Clin Infect Dis. 2024. PMID: 38335094 Free PMC article.
References
-
- Capeau J, Bouteloup V, Katlama C, Bastard JP, Guiyedi V, Salmon-Ceron D, et al. Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment. AIDS 2012; 26(3):303–314. - PubMed
-
- Tebas P Insulin resistance and diabetes mellitus associated with antiretroviral use in HIV-infected patients: pathogenesis, prevention, and treatment options. J Acquir Immune Defic Syndr 2008; 49 Suppl 2:S86–92. - PubMed
-
- Monroe AK, Glesby MJ, Brown TT. Diagnosing and managing diabetes in HIV-infected patients: current concepts. Clin Infect Dis 2015; 60(3):453–462. - PubMed
-
- Ghehi C, Gabillard D, Moh R, Badje A, Kouame GM, Oouttara E, et al. High correlation between Framingham equations with BMI and with lipids to estimate cardiovascular risks score at baseline in HIV-infected adults in the Temprano trial, ANRS 12136 in Cote d’Ivoire. PLoS One 2017; 12(6):e0177440. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 HL146245/HL/NHLBI NIH HHS/United States
- U01 HL146205/HL/NHLBI NIH HHS/United States
- U01 HL146208/HL/NHLBI NIH HHS/United States
- K24 AI120834/AI/NIAID NIH HHS/United States
- U01 AI034989/AI/NIAID NIH HHS/United States
- U01 HL146192/HL/NHLBI NIH HHS/United States
- U01 HL146193/HL/NHLBI NIH HHS/United States
- U01 AI103401/AI/NIAID NIH HHS/United States
- U01 AI103390/AI/NIAID NIH HHS/United States
- U01 HL146194/HL/NHLBI NIH HHS/United States
- U01 HL146241/HL/NHLBI NIH HHS/United States
- P30 AI027767/AI/NIAID NIH HHS/United States
- P30 AI050409/AI/NIAID NIH HHS/United States
- U01 HL146333/HL/NHLBI NIH HHS/United States
- U01 AI035041/AI/NIAID NIH HHS/United States
- U01 HL146242/HL/NHLBI NIH HHS/United States
- U01 AI034994/AI/NIAID NIH HHS/United States
- U01 HL146201/HL/NHLBI NIH HHS/United States
- U01 HL146204/HL/NHLBI NIH HHS/United States
- U01 HL146202/HL/NHLBI NIH HHS/United States
- UL1 TR000004/TR/NCATS NIH HHS/United States
- U01 HL146240/HL/NHLBI NIH HHS/United States
- U01 HL146203/HL/NHLBI NIH HHS/United States
- UL1 TR003098/TR/NCATS NIH HHS/United States
- P30 AI050410/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous